Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
Raffaella Maria Gadaleta, Oihane García‐Irigoyen, Marica Cariello, et al.
EBioMedicine (2020) Vol. 54, pp. 102719-102719
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Jie Cai, Lulu Sun, Frank J. Gonzalez
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 289-300
Open Access | Times Cited: 441
Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 303
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Lulu Sun, Jie Cai, Frank J. Gonzalez
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 5, pp. 335-347
Closed Access | Times Cited: 283
Bile Acid Signaling in Inflammatory Bowel Diseases
Stefano Fiorucci, Adriana Carino, Monia Baldoni, et al.
Digestive Diseases and Sciences (2020) Vol. 66, Iss. 3, pp. 674-693
Open Access | Times Cited: 161
Bile acids as modulators of gut microbiota composition and function
Anaïs Larabi, Hugo L. P. Masson, Andreas J. Bäumler
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 143
Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
Min Yang, Yu Gu, Lingfeng Li, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3143-3143
Open Access | Times Cited: 125
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 98
Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
Lucilla Crudele, Raffaella Maria Gadaleta, Marica Cariello, et al.
EBioMedicine (2023) Vol. 97, pp. 104821-104821
Open Access | Times Cited: 97
Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
Linsen Shi, Lihua Jin, Wendong Huang
Cells (2023) Vol. 12, Iss. 14, pp. 1888-1888
Open Access | Times Cited: 47
Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts
Palak Trivedi, Gideon M. Hirschfield, David H. Adams, et al.
Gastroenterology (2024) Vol. 166, Iss. 6, pp. 995-1019
Closed Access | Times Cited: 22
The role of the gut microbiota in tumor, immunity, and immunotherapy
Yuyan Xie, Fang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
Junwei Xiang, Zhengyan Zhang, Hong-Yi Xie, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 80
Bile acids and their receptors in regulation of gut health and diseases
Sen Lin, Sutian Wang, Peng Wang, et al.
Progress in Lipid Research (2022) Vol. 89, pp. 101210-101210
Open Access | Times Cited: 50
Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism
Xiongjie Sun, Yu Zhang, Gang Cheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115430-115430
Open Access | Times Cited: 36
Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases
Luyao Shen, Yongsheng Li, Huakan Zhao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Bile acid metabolism and circadian rhythms
Yunxia Yang, Jianfa Zhang
AJP Gastrointestinal and Liver Physiology (2020) Vol. 319, Iss. 5, pp. G549-G563
Closed Access | Times Cited: 67
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, et al.
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100284-100284
Open Access | Times Cited: 43
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
Kemp M. Anderson, Christopher P. Gayer
Cells (2021) Vol. 10, Iss. 11, pp. 3206-3206
Open Access | Times Cited: 43
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 550-550
Open Access | Times Cited: 35
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
Raffaella Maria Gadaleta, Marica Cariello, Lucilla Crudele, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3212-3212
Open Access | Times Cited: 35
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19
Alessandra Soares‐Schanoski, Natalie Sauerwald, Carl Goforth, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Gut Microbiota Modulation and Its Implications on Neuropathic Pain: A Comprehensive Literature Review
Alberto Corriero, Mariateresa Giglio, Francesco Inchingolo, et al.
Pain and Therapy (2023) Vol. 13, Iss. 1, pp. 33-51
Open Access | Times Cited: 21
Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans
Teresa Padró, Victoria de Santisteban Villaplana, Pol Huedo, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 708-722
Open Access | Times Cited: 6
Bile Acid Signaling in Inflammatory Bowel Disease
Mariusz A. Bromke, Małgorzata Krzystek‐Korpacka
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9096-9096
Open Access | Times Cited: 37
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial
Xiaotao Zhang, Ehsan Irajizad, Kristi L. Hoffman, et al.
EBioMedicine (2023) Vol. 98, pp. 104873-104873
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top